Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
CLDI on NYSE
Shares outstanding
7,179,487
Price per share
$1.12
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
211,448
Total reported value
$321,773
% of total 13F portfolios
0%
Share change
+211,448
Value change
+$321,774
Number of holders
22
Price from insider filings
$1.12
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lincoln Alternative Strategies LLC 14% $1,248,300 730,000 Lincoln Alternative Strategies LLC 20 Aug 2025
Gavrilov Ognian Anguelov 7.8% $659,792 560,000 Gavrilov Ognian Anguelov 20 Aug 2025
ARMISTICE CAPITAL, LLC 5% $200,699 117,368 Armistice Capital, LLC 30 Jun 2025

As of 30 Sep 2025, 22 institutional investors reported holding 211,448 shares of Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI). This represents 2.9% of the company’s total 7,179,487 outstanding shares.

Institutional Holders of Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 156,318 $182,895 +$14,820 $1.17 11
2025 Q3 211,448 $321,773 +$321,774 $1.52 22